233 related articles for article (PubMed ID: 30899975)
1. MDCT findings predicting post-operative residual tumor and survival in patients with pancreatic cancer.
Bae JS; Kim JH; Joo I; Chang W; Han JK
Eur Radiol; 2019 Jul; 29(7):3714-3724. PubMed ID: 30899975
[TBL] [Abstract][Full Text] [Related]
2. Prediction of residual tumor and overall survival after first-line surgery in patients with pancreatic ductal adenocarcinoma using preoperative magnetic resonance imaging findings.
Bae JS; Kim JH; Kang HJ; Han JK
Acta Radiol; 2022 Apr; 63(4):435-446. PubMed ID: 33682455
[TBL] [Abstract][Full Text] [Related]
3. CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture analysis.
Kim BR; Kim JH; Ahn SJ; Joo I; Choi SY; Park SJ; Han JK
Eur Radiol; 2019 Jan; 29(1):362-372. PubMed ID: 29931561
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the prognostic impact of pre- and post-operative CA19-9, SPan-1, and DUPAN-II levels in patients with pancreatic carcinoma.
Kondo N; Murakami Y; Uemura K; Nakagawa N; Takahashi S; Ohge H; Sueda T
Pancreatology; 2017; 17(1):95-102. PubMed ID: 27746094
[TBL] [Abstract][Full Text] [Related]
5. Preoperative CT findings for prediction of resectability in patients with gallbladder cancer.
Choi SY; Kim JH; Park HJ; Han JK
Eur Radiol; 2019 Dec; 29(12):6458-6468. PubMed ID: 31254061
[TBL] [Abstract][Full Text] [Related]
6. Important CT and histopathological findings for recurrence and overall survival in patients with pancreatic ductal adenocarcinoma who underwent surgery after neoadjuvant FOLFIRINOX.
Park SJ; Kim JH; Joo I; Lee KB; Han JK
Eur Radiol; 2021 Jun; 31(6):3616-3626. PubMed ID: 33201279
[TBL] [Abstract][Full Text] [Related]
7. Microscopic resection margin status in pancreatic ductal adenocarcinoma - A nationwide analysis.
Daamen LA; van Goor IWJM; Schouten TJ; Dorland G; van Roessel SR; Besselink MG; Bonsing BA; Bosscha K; Brosens LAA; Busch OR; van Dam RM; Fariña Sarasqueta A; Festen S; Groot Koerkamp B; van der Harst E; de Hingh IHJT; Intven MPW; Kazemier G; de Meijer VE; Nieuwenhuijs VB; Raicu GM; Roos D; Schreinemakers JMJ; Stommel MWJ; van Velthuysen MF; Verheij J; Verkooijen HM; van Santvoort HC; Molenaar IQ;
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):708-716. PubMed ID: 33323293
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic adenocarcinoma: quantitative CT features are correlated with fibrous stromal fraction and help predict outcome after resection.
Cai X; Gao F; Qi Y; Lan G; Zhang X; Ji R; Xu Y; Liu C; Shi Y
Eur Radiol; 2020 Sep; 30(9):5158-5169. PubMed ID: 32346792
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma.
Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
Scand J Gastroenterol; 2019 Jun; 54(6):780-786. PubMed ID: 31180790
[No Abstract] [Full Text] [Related]
10. Diagnostic performance of MDCT for predicting important prognostic factors in pancreatic cancer.
Kim JH; Eun HW; Kim KW; Lee JY; Lee JM; Han JK; Choi BI
Pancreas; 2013 Nov; 42(8):1316-22. PubMed ID: 24152957
[TBL] [Abstract][Full Text] [Related]
11. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Platelet-to-Albumin Ratio Predicts Prognosis of Patients with Pancreatic Ductal Adenocarcinoma After Pancreatic Resection.
Shirai Y; Shiba H; Haruki K; Horiuchi T; Saito N; Fujiwara Y; Sakamoto T; Uwagawa T; Yanaga K
Anticancer Res; 2017 Feb; 37(2):787-793. PubMed ID: 28179331
[TBL] [Abstract][Full Text] [Related]
13. Is pancreatectomy with arterial reconstruction a safe and useful procedure for locally advanced pancreatic cancer?
Amano H; Miura F; Toyota N; Wada K; Katoh K; Hayano K; Kadowaki S; Shibuya M; Maeno S; Eguchi T; Takada T; Asano T
J Hepatobiliary Pancreat Surg; 2009; 16(6):850-7. PubMed ID: 19844653
[TBL] [Abstract][Full Text] [Related]
14. Comparison of double contrast-enhanced ultrasound and MDCT for assessing vascular involvement of pancreatic adenocarcinoma: preliminary results correlated with surgical findings.
Li S; Huang P; Xu H; Xu K; Wu X
Ultraschall Med; 2012 Dec; 33(7):E299-E305. PubMed ID: 22549812
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis.
de Rooij T; Tol JA; van Eijck CH; Boerma D; Bonsing BA; Bosscha K; van Dam RM; Dijkgraaf MG; Gerhards MF; van Goor H; van der Harst E; de Hingh IH; Kazemier G; Klaase JM; Molenaar IQ; Patijn GA; van Santvoort HC; Scheepers JJ; van der Schelling GP; Sieders E; Busch OR; Besselink MG;
Ann Surg Oncol; 2016 Feb; 23(2):585-91. PubMed ID: 26508153
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail.
Kitamura K; Esaki M; Sone M; Sugawara S; Hiraoka N; Nara S; Ban D; Takamoto T; Mizui T; Shimada K
Ann Surg Oncol; 2022 Oct; 29(11):7047-7058. PubMed ID: 35691957
[TBL] [Abstract][Full Text] [Related]
17. Clinical predictive factors of long-term survival after curative resection of pancreatic cancer: a retrospective study.
Nakano Y; Kitago M; Shinoda M; Abe Y; Yagi H; Hibi T; Takeuchi A; Aiura K; Itano O; Kitagawa Y
Cancer Med; 2017 Oct; 6(10):2278-2286. PubMed ID: 28925039
[TBL] [Abstract][Full Text] [Related]
18. Prediction of vascular involvement and resectability by multidetector-row CT versus MR imaging with MR angiography in patients who underwent surgery for resection of pancreatic ductal adenocarcinoma.
Lee JK; Kim AY; Kim PN; Lee MG; Ha HK
Eur J Radiol; 2010 Feb; 73(2):310-6. PubMed ID: 19070981
[TBL] [Abstract][Full Text] [Related]
19. Resection for recurrent pancreatic cancer in the remnant pancreas after pancreatectomy is clinically promising: Results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Yamada S; Kobayashi A; Nakamori S; Baba H; Yamamoto M; Yamaue H; Fujii T
Surgery; 2018 Nov; 164(5):1049-1056. PubMed ID: 30068484
[TBL] [Abstract][Full Text] [Related]
20. Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma.
Shin DW; Lee JC; Kim J; Woo SM; Lee WJ; Han SS; Park SJ; Choi KS; Cha HS; Yoon YS; Han HS; Hong EK; Hwang JH
Eur J Surg Oncol; 2019 Nov; 45(11):2159-2165. PubMed ID: 31202572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
